Xiangyang YE
7Patents
1h-index
4Co-inventors
33Inventor score
Filing activity: May 27, 2017 → Jul 23, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10730887B2 | Compound containing tricyclic heteroaryl group | Emerging Cross-Sectional Technologies | 1 | Active |
| US11352353B2 | Heterocyclic compound serving as FGFR4 inhibitor | Chemistry; Metallurgy | 1 | Active |
| US12358911B2 | Heterocyclic comipound as CDK-HDAC dual pathway inhibitor | Chemistry; Metallurgy | 0 | Active |
| US10968234B2 | Compound containing tricyclic heteroaryl group | Emerging Cross-Sectional Technologies | 0 | Active |
| US11142535B2 | Heterocyclic compound as Syk inhibitor and/or Syk-HDAC dual inhibitor | Chemistry; Metallurgy | 0 | Active |
| US12415797B2 | Heterocyclic compound as CDK-HDAC double-channel inhibitor | Chemistry; Metallurgy | 0 | Active |
| US11266640B2 | Polycyclic compound acting as IDO inhibitor and/or IDO-HDAC dual inhibitor | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.